Literature DB >> 28285346

Complex Changes in the Innate and Adaptive Immunity Accompany Progressive Degeneration of the Nigrostriatal Pathway Induced by Intrastriatal Injection of 6-Hydroxydopamine in the Rat.

Giulia Ambrosi1, Natasa Kustrimovic2, Francesca Siani1, Emanuela Rasini2, Silvia Cerri1, Cristina Ghezzi1, Giuseppe Dicorato1, Sofia Caputo1, Franca Marino2, Marco Cosentino2, Fabio Blandini3.   

Abstract

We investigated changes in innate and adaptive immunity paralleling the progressive nigrostriatal damage occurring in a neurotoxic model of Parkinson's disease (PD) based on unilateral infusion of 6-hydroxydopamine (6-OHDA) into the rat striatum. A time-course analysis was conducted to assess changes in morphology (activation) and cell density of microglia and astrocytes, microglia polarization (M1 vs. M2 phenotype), lymphocyte infiltration in the lesioned substantia nigra pars compacta (SNc), and modifications of CD8+ and subsets of CD4+ T cell in peripheral blood accompanying nigrostriatal degeneration. Confirming previous results, we observed slightly different profiles of activation for astrocytes and microglia paralleling nigral neuronal loss. For astrocytes, morphological changes and cell density increases were mostly evident at the latest time points (14 and 28 days post-surgery), while moderate microglia activation was present since the earliest time point. For the first time, in this model, we described the time-dependent profile of microglia polarization. Activated microglia clearly expressed the M2 phenotype in the earlier phase of the experiment, before cell death became manifest, gradually shifting to the M1 phenotype as SNc cell death started. In parallel, a reduction in the percentage of circulating CD4+ T regulatory (Treg) cells, starting as early as day 3 post-6-OHDA injection, was detected in 6-OHDA-injected rats. Our data show that nigrostriatal degeneration is associated with complex changes in central and peripheral immunity. Microglia activation and polarization, Treg cells, and the factors involved in their cross-talk should be further investigated as targets for the development of therapeutic strategies for disease modification in PD.

Entities:  

Keywords:  6-OHDA; Astrocytes; Microglia; Parkinson’s disease; Rat; T regulatory cells

Mesh:

Substances:

Year:  2017        PMID: 28285346     DOI: 10.1007/s12640-017-9712-2

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  55 in total

Review 1.  Regulatory T cells in the central nervous system.

Authors:  Daniel E Lowther; David A Hafler
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases.

Authors:  M Levite
Journal:  Acta Physiol (Oxf)       Date:  2015-09-24       Impact factor: 6.311

3.  Alterations of T-lymphocyte populations in Parkinson disease.

Authors:  Yasuhiko Baba; Ataru Kuroiwa; Ryan J Uitti; Zbigniew K Wszolek; Tatsuo Yamada
Journal:  Parkinsonism Relat Disord       Date:  2005-09-09       Impact factor: 4.891

4.  Adhesion molecules as potential targets for neuroprotection in a rodent model of Parkinson's disease.

Authors:  Marie-Therese Armentero; Giovanna Levandis; Eleonora Bazzini; Silvia Cerri; Cristina Ghezzi; Fabio Blandini
Journal:  Neurobiol Dis       Date:  2011-06-12       Impact factor: 5.996

5.  6-Hydroxydopamine-induced alterations in blood-brain barrier permeability.

Authors:  P M Carvey; C H Zhao; B Hendey; H Lum; J Trachtenberg; B S Desai; J Snyder; Y G Zhu; Z D Ling
Journal:  Eur J Neurosci       Date:  2005-09       Impact factor: 3.386

6.  Microglial activation and chronic neurodegeneration.

Authors:  Melinda E Lull; Michelle L Block
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

7.  Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model.

Authors:  Fabio Blandini; Giovanna Levandis; Eleonora Bazzini; Giuseppe Nappi; Marie-Therese Armentero
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

8.  The effects of aging, injury and disease on microglial function: a case for cellular senescence.

Authors:  Kelly R Miller; Wolfgang J Streit
Journal:  Neuron Glia Biol       Date:  2007-08

Review 9.  The role of innate and adaptive immunity in Parkinson's disease.

Authors:  George T Kannarkat; Jeremy M Boss; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

Review 10.  Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain.

Authors:  Geeta Ramesh; Andrew G MacLean; Mario T Philipp
Journal:  Mediators Inflamm       Date:  2013-08-12       Impact factor: 4.711

View more
  10 in total

1.  Longitudinal PET Imaging of α7 Nicotinic Acetylcholine Receptors with [18F]ASEM in a Rat Model of Parkinson's Disease.

Authors:  Steven Vetel; Johnny Vercouillie; Frédéric Buron; Jackie Vergote; Clovis Tauber; Julie Busson; Gabrielle Chicheri; Sylvain Routier; Sophie Sérrière; Sylvie Chalon
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

Review 2.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

Review 3.  Neuroinflammation in Parkinson's Disease - Putative Pathomechanisms and Targets for Disease-Modification.

Authors:  Alexander Grotemeyer; Rhonda Leah McFleder; Jingjing Wu; Jörg Wischhusen; Chi Wang Ip
Journal:  Front Immunol       Date:  2022-05-18       Impact factor: 8.786

4.  DAT and TH expression marks human Parkinson's disease in peripheral immune cells.

Authors:  Adithya Gopinath; Phillip Mackie; Basil Hashimi; Anna Marie Buchanan; Aidan R Smith; Rachel Bouchard; Gerry Shaw; Martin Badov; Leila Saadatpour; Aryn Gittis; Adolfo Ramirez-Zamora; Michael S Okun; Wolfgang J Streit; Parastoo Hashemi; Habibeh Khoshbouei
Journal:  NPJ Parkinsons Dis       Date:  2022-06-07

5.  Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease.

Authors:  Francesca Siani; Rosaria Greco; Giovanna Levandis; Cristina Ghezzi; Francesca Daviddi; Chiara Demartini; Elisabetta Vegeto; Marie-Thérèse Fuzzati-Armentero; Fabio Blandini
Journal:  Front Neurosci       Date:  2017-05-31       Impact factor: 4.677

Review 6.  Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells.

Authors:  Francesca Garretti; Dritan Agalliu; Cecilia S Lindestam Arlehamn; Alessandro Sette; David Sulzer
Journal:  Front Immunol       Date:  2019-02-25       Impact factor: 7.561

Review 7.  Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment.

Authors:  Divine C Nwafor; Allison L Brichacek; Afroz S Mohammad; Jessica Griffith; Brandon P Lucke-Wold; Stanley A Benkovic; Werner J Geldenhuys; Paul R Lockman; Candice M Brown
Journal:  J Cent Nerv Syst Dis       Date:  2019-04-09

Review 8.  Dwellers and Trespassers: Mononuclear Phagocytes at the Borders of the Central Nervous System.

Authors:  Daniela C Ivan; Sabrina Walthert; Kristina Berve; Jasmin Steudler; Giuseppe Locatelli
Journal:  Front Immunol       Date:  2021-03-05       Impact factor: 7.561

9.  Dopamine D2-Subtype Receptors Outside the Blood-Brain Barrier Mediate Enhancement of Mesolimbic Dopamine Release and Conditioned Place Preference by Intravenous Dopamine.

Authors:  J Daniel Obray; Christina A Small; Emily K Baldwin; Eun Young Jang; Jin Gyeom Lee; Chae Ha Yang; Jordan T Yorgason; Scott C Steffensen
Journal:  Front Cell Neurosci       Date:  2022-07-12       Impact factor: 6.147

10.  Pre-clinical Studies Identifying Molecular Pathways of Neuroinflammation in Parkinson's Disease: A Systematic Review.

Authors:  Mobina Fathi; Kimia Vakili; Shirin Yaghoobpoor; Mohammad Sadegh Qadirifard; Mohammadreza Kosari; Navid Naghsh; Afsaneh Asgari Taei; Andis Klegeris; Mina Dehghani; Ashkan Bahrami; Hamed Taheri; Ashraf Mohamadkhani; Ramtin Hajibeygi; Mostafa Rezaei Tavirani; Fatemeh Sayehmiri
Journal:  Front Aging Neurosci       Date:  2022-07-04       Impact factor: 5.702

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.